Skip to main content
. 2023 Jul 27;202(2):245–255. doi: 10.1007/s10549-023-07065-0

Table 2.

Overall results of sentinel node analysis

Parameter Histology n = 35,143 % OSNA n = 1086 % P-value
Macrometastasis 4449 12.7 116 10.7 0.053
Micrometastasis 2771 7.9 162 14.9  < 0.001
Axillary therapy* 0.083
 Yes 5046 14.4 155 14.3
 No 29,937 85.2 931 85.7
 Unknown 160 0.5 0 0.0
Axillary lymph node dissection 723 2.1 60 5.5  < 0.001
Axillary radiotherapy  < 0.001
 Yes 4323 12.3 95 8.7
 No 30,660 87.2 991 91.3
 Unknown 160 0.5 0 0.0
Chemotherapy** 6655 18.9 229 21.1 0.075
Endocrine therapy 17,852 50.8 497 45.8 0.001
Chemotherapy and endocrine therapy 4873 13.9 133 12.2 0.128

Significant differences are bold

*Axillary lymph node dissection or axillary radiotherapy

**Chemotherapy with or without (targeted) immunotherapy. Statistical analysis was performed using Pearson Chi-square test